BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8150596)

  • 1. Differential behaviour in pancreas and heart of two coxsackievirus B3 variants.
    Gómez RM; Cui X; Castagnino CG; Berría MI
    Intervirology; 1993; 36(3):153-60. PubMed ID: 8150596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine acinar pancreatitis preceding necrotizing myocarditis after Coxsackievirus B3 inoculation.
    Gómez RM; Lascano EF; Berría MI
    J Med Virol; 1991 Oct; 35(2):71-5. PubMed ID: 1662707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.
    Zhang H; Yousef GE; Ouyang X; Archard LC
    Int J Exp Pathol; 1994 Apr; 75(2):99-110. PubMed ID: 8199011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural study of cell injury induced by coxsackievirus B3 in pancreatic and cardiac tissues.
    Gómez RM; Lopez Costa JJ; Pecci Saavedra G; Berria MI
    Medicina (B Aires); 1993; 53(4):300-6. PubMed ID: 8201911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleotide differences of coxsackievirus B3 and chronic myocarditis.
    Kishimoto C; Takamatsu N; Ochiai H; Kuribayashi K
    Heart Vessels; 2015 Jan; 30(1):126-35. PubMed ID: 24493328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains.
    Gauntt CJ; Gomez PT; Duffey PS; Grant JA; Trent DW; Witherspoon SM; Paque RE
    J Virol; 1984 Nov; 52(2):598-605. PubMed ID: 6092681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyocarditic coxsackievirus B3 causes myocarditis in immunocompromised mice.
    Takada H; Kishimoto C; Kurokawa M; Hiraoka Y
    Exp Clin Cardiol; 2003; 8(2):71-5. PubMed ID: 19641653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of myocarditic variants of Coxsackievirus B3 in inbred mice. A pathologic characterization of heart tissue damage.
    Chow LH; Gauntt CJ; McManus BM
    Lab Invest; 1991 Jan; 64(1):55-64. PubMed ID: 1990209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice.
    Tracy S; Höfling K; Pirruccello S; Lane PH; Reyna SM; Gauntt CJ
    J Med Virol; 2000 Sep; 62(1):70-81. PubMed ID: 10935991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coxsackievirus B3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes.
    Shen Y; Kan QC; Xu W; Chu YW; Xiong SD
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):1-9. PubMed ID: 19279353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing cardiotropic and myocarditic properties of group B type 4 coxsackievirus strains.
    Cao Y; Schnurr DP; Schmidt NJ
    Arch Virol; 1984; 80(2-3):119-30. PubMed ID: 6326709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model.
    Trousdale MD; Paque RE; Nealon T; Gauntt CJ
    Infect Immun; 1979 Feb; 23(2):486-95. PubMed ID: 217832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice.
    Wolfgram LJ; Beisel KW; Herskowitz A; Rose NR
    J Immunol; 1986 Mar; 136(5):1846-52. PubMed ID: 3005402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
    Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased virulence of a human enterovirus (coxsackievirus B3) in selenium-deficient mice.
    Beck MA; Kolbeck PC; Shi Q; Rohr LH; Morris VC; Levander OA
    J Infect Dis; 1994 Aug; 170(2):351-7. PubMed ID: 8035022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine natural killer cells limit coxsackievirus B3 replication.
    Godeny EK; Gauntt CJ
    J Immunol; 1987 Aug; 139(3):913-8. PubMed ID: 3036947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in virulence of Coxsackie virus B3 in the heart of mice, II. Pathological comparison.
    Hashimoto I; Komatsu T; Kohara T
    Microbiol Immunol; 1983; 27(4):335-45. PubMed ID: 6310354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coxsackievirus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes.
    Lyden DC; Olszewski J; Feran M; Job LP; Huber SA
    Am J Pathol; 1987 Mar; 126(3):432-8. PubMed ID: 3030117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice.
    Gauntt CJ; Trousdale MD; LaBadie DR; Paque RE; Nealon T
    J Med Virol; 1979; 3(3):207-20. PubMed ID: 225441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coxsackievirus B3-induced acute pancreatitis: analysis of histopathological and viral parameters in a mouse model.
    Vuorinen T; Kallajoki M; Hyypiä T; Vainionpää R
    Br J Exp Pathol; 1989 Aug; 70(4):395-403. PubMed ID: 2548562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.